fingolimod hydrochloride has been researched along with Lupus Nephritis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chang, S; Chen, J; Fan, W; Huang, T; Kang, J; Tian, J; Wang, J; Wang, Y; Xu, H | 1 |
Chang, D; Chen, W; Cheng, Y; Dai, W; Fan, L; Ge, S; Guo, K; Li, M; Li, Y; Liu, L; Liu, T; Luo, R; Pei, G; Wang, Z; Xu, G; Xu, Y; Yao, Y; Zhang, C; Zhang, N; Zuo, M | 1 |
Amano, E; Amano, H; Ando, S; Hirose, S; Hou, R; Lin, Q; Minowa, K; Morimoto, S; Nakano, S; Nakiri, Y; Ohtsuji, M; Takasaki, Y; Tokano, Y; Tsurui, H; Watanabe, T | 1 |
Alperovich, G; Bolaños, N; Carrera, M; Cruzado, JM; Franquesa, M; Gomà, M; Grinyó, JM; Herrero-Fresneda, I; Lloberas, N; Poveda, R; Rama, I; Torras, J | 1 |
4 other study(ies) available for fingolimod hydrochloride and Lupus Nephritis
Article | Year |
---|---|
S1P/S1PR1 axis promotes macrophage M1 polarization through NLRP3 inflammasome activation in Lupus nephritis.
Topics: Animals; Fingolimod Hydrochloride; Inflammasomes; Inflammation; Lupus Erythematosus, Systemic; Lupus Nephritis; Macrophages; Mice; Mice, Inbred MRL lpr; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Sphingosine-1-Phosphate Receptors | 2023 |
Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A.
Topics: Adult; Animals; Disease Progression; Female; Fingolimod Hydrochloride; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Interleukin-17; Kidney; Lupus Nephritis; Male; Mice; Mice, Knockout; Middle Aged; Nephrosis, Lipoid; Renal Insufficiency, Chronic; Tertiary Lymphoid Structures | 2021 |
FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice.
Topics: Animals; Antibodies, Antinuclear; Fingolimod Hydrochloride; Immunosuppressive Agents; Leukocyte Count; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocytes; Mesangial Cells; Mice; Monocytes; Propylene Glycols; Sphingosine; Spleen | 2010 |
New immunosuppresor strategies in the treatment of murine lupus nephritis.
Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Apoptosis; Autoantigens; Cell Movement; Chromatin; Complement C3; Complement C3 Nephritic Factor; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fingolimod Hydrochloride; Glomerular Mesangium; Immunoglobulin G; Immunosuppressive Agents; Injections, Intraperitoneal; Kidney Glomerulus; Lupus Nephritis; Lymphocytes; Mice; Mice, Inbred NZB; Nucleosomes; Propylene Glycols; Proteinuria; Receptors, Lysosphingolipid; Sirolimus; Sphingosine | 2007 |